Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek New York, USA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key...

Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight New York, USA, June 29, 2022 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight The rising incidence of COPD and the exacerbations...

Chronic Obstructive Pulmonary Disease Forecast and Market Report 2021-2026: Treatments, Edipemiology, Marketed & Pipeline Drugs, Licensing, Clinical Trials, Future Trends Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease Forecast and Market Analysis to 2026" drug pipelines has been added to ResearchAndMarkets.com's offering. Chronic...